Brilliant 2 days at MILD|25 course with excellent organisation, speakers & talks on ILD, HRCT, PPF, HP, OLD, PH, transplant, MDT, myositis, SARD-ILD, CLD, sarcoid, genetics, exacerbations, ILAs & the horizon. Thanks for the invitation to speak to pharmacological considerations in ILD!

Ramadhan Kareem 🌙 This year, more than ever, I look forward to a month of discipline, abstinence, charity, worship and reflection. I hope for peace, spiritual growth and prosperity for all in this blessed month and beyond 🤍

📢 Call for Abstracts Have a project that improves patient care? Submit your abstract for our Summer Meeting and showcase your work in respiratory medicine! 🗓️ 19–20 June, Manchester Deadline: 10 March 2025 https://buff.ly/3Efdnt0 #BTSummerMeeting #RespiratoryCare

It’s been 3/12 since I started my pre-doc fellowship and the question I ask myself daily is, “am I doing enough?” The transition from clinician to clinical researcher has been incredibly exciting and it is important that I make the most of each day.

We’re conducting a quick, anonymous survey to better understand current practices for managing interstitial lung abnormalities (ILAs) in the UK. Your insights can help improve care pathways and outcomes. ⏱️ Takes just 5 minutes to complete! 👉 tinyurl.com/ytsupxwk Thanks

"The work by @US_FDA underscores the fact that data from oximeters is only one part of the larger clinical picture, and that strong clinical judgement is still central to medical decision making," said ATS member Indira Gurubhagavatula, MD, MPH, chair of SRN assembly. www.healio.com/news/pulmono...

1st January marks the end of my term as co-chair of ILD-IN. I am incredibly proud of our achievements and how much we have grown. I hope we have been able to make a difference and support HCPs deliver the best care possible to people with ILD. Here are a few highlights of my term: